Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019

OBJECTIVES: To determine whether placental cell therapy PLacental eXpanded (PLX)-PAD (Pluristem Therapeutics, Haifa, Israel) may be beneficial to treating critically ill patients suffering from acute respiratory distress syndrome due to coronavirus disease 2019. DESIGN: Retrospective case report of...

Descripción completa

Detalles Bibliográficos
Autores principales: Barkama, Ravit, Mayo, Ami, Paz, Alona, Solopov, Anna, Mann, Tal, Vadasz, Zahava, Appel, Tal, Ofir, Racheli, Shani, Liran, Sheleg, Michal, Allen, Hoshea, Shaked Nitzan, Rony, Tsarfaty, Nurit, Gilad, Hadar, Birch, Thomas, Kachel, Erez, Reinke, Petra, Volk, Hans-Dieter, Zalts, Ronen, Raz Pasteur, Ayelet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498138/
https://www.ncbi.nlm.nih.gov/pubmed/32984833
http://dx.doi.org/10.1097/CCE.0000000000000207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498138/
https://www.ncbi.nlm.nih.gov/pubmed/32984833
http://dx.doi.org/10.1097/CCE.0000000000000207

Ejemplares similares